Company

Oncopeptides AB

Headquarters: Stockholm, Sweden

Employees: 162

OMX: ONCO

Market Cap

kr548.7 Million

SEK as of July 1, 2024

US$51.7 Million

Market Cap History

Oncopeptides AB market capitalization over time

Evolution of Oncopeptides AB market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Oncopeptides AB

Detailed Description

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

Top 1-year algo backtest: +227.67%

$10,000 in September 2023 would now be $32,767 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Oncopeptides AB has the following listings and related stock indices.


Stock: OMX: ONCO wb_incandescent

Stock: FSX: OND wb_incandescent

Details

Headquarters:

Vastra Tradgardsgatan 15

Stockholm, 111 53

Sweden

Phone: 46 86 15 20 40